ストックスクリーナーアプリを入手
34.31
2.76%
0.92
前日終値:
$33.39
開ける：
$33.32
24時間の取引高:
777.65K
Relative Volume:
0.86
時価総額：
$1.98B
収益：
$772.53M
当期純損益:
$180.90M
株価収益率:
11.06
EPS:
3.1024
ネットキャッシュフロー:
$258.73M
1週間 パフォーマンス:
+0.82%
1か月 パフォーマンス:
+31.15%
6か月 パフォーマンス:
-0.55%
1年 パフォーマンス:
+3.25%
1日の値動き範囲:
$33.21
$35.00
1週間の範囲:
$32.77
$35.00
52週間の値動き範囲:
$25.52
$40.93
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
名前
Harmony Biosciences Holdings Inc
セクター
電話
(484) 539-9800
住所
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
HRMY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
34.31 | 1.92B | 772.53M | 180.90M | 258.73M | 3.1024 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-21 | 開始されました | Truist | Buy |
| 2025-07-10 | 再開されました | Goldman | Neutral |
| 2025-06-02 | 再開されました | Oppenheimer | Outperform |
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-12-17 | 開始されました | H.C. Wainwright | Buy |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-09-10 | 開始されました | UBS | Buy |
| 2024-06-21 | 開始されました | Citigroup | Buy |
| 2024-01-02 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-09-25 | ダウングレード | Goldman | Neutral → Sell |
| 2023-09-07 | 開始されました | Berenberg | Buy |
| 2023-04-20 | 開始されました | BofA Securities | Neutral |
| 2022-10-14 | アップグレード | Janney | Neutral → Buy |
| 2022-10-14 | アップグレード | Jefferies | Hold → Buy |
| 2022-08-03 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-13 | ダウングレード | Goldman | Buy → Neutral |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-04-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-04 | 開始されました | Raymond James | Outperform |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-03-29 | アップグレード | Goldman | Neutral → Buy |
| 2020-09-14 | 開始されました | Goldman | Neutral |
| 2020-09-14 | 開始されました | Jefferies | Buy |
| 2020-09-14 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Harmony Biosciences Holdings Inc (HRMY) 最新ニュース
Is Harmony Biosciences Holdings Inc. stock supported by strong cash flows2025 Technical Overview & Smart Investment Allocation Tips - newser.com
A Piece Of The Puzzle Missing From Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) 28% Share Price Climb - simplywall.st
Harmony Biosciences Announces Initiation of First-In-Human Study With Potential Best-In-Class Orexin 2 Receptor Agonist (BP1.15205) for Central Disorders of Hypersomnolence - BioSpace
What insider trading reveals about Harmony Biosciences Holdings Inc. stockEarnings Growth Report & Low Risk Entry Point Guides - newser.com
Harmony Advances First Human Study of Orexin 2 Agonist - Sleep Review
Why Harmony Biosciences Holdings Inc. stock is favored by top institutionsInsider Buying & Safe Capital Investment Plans - newser.com
Why Harmony Biosciences Holdings Inc. stock could benefit from AI revolution - newser.com
Harmony Biosciences Initiates Patient Dosing in BP1.15205 Study for Central Disorders of Hypersomnolence - MarketScreener
Using Ichimoku Cloud for Harmony Biosciences Holdings Inc. technicalsWeekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com
Harmony Biosciences to Participate in Upcoming Investor Conferences - Business Wire
(HRMY) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Harmony Biosciences reports Q3 revenue of $239M, raises FY25 revenue guidance - MSN
What technical signals suggest for Harmony Biosciences Holdings Inc. stockForecast Cut & AI Forecast Swing Trade Picks - newser.com
Harmony Biosciences Surges on Strong WAKIX Growth as Cash Position Climbs to $778M - MyChesCo
How interest rate cuts could boost Harmony Biosciences Holdings Inc. stockEarnings Recap Report & Daily Market Momentum Tracking - newser.com
Will Harmony Biosciences Holdings Inc. stock gain from lower inflation2025 Market Outlook & Long Hold Capital Preservation Tips - newser.com
Will Harmony Biosciences Holdings Inc. outperform the marketGlobal Markets & High Win Rate Trade Alerts - newser.com
Is Harmony Biosciences Holdings Inc. stock a top momentum play2025 Market Outlook & Stepwise Entry and Exit Trade Signals - newser.com
Sector ETF performance correlation with Harmony Biosciences Holdings Inc.2025 Market Sentiment & Free Reliable Trade Execution Plans - newser.com
Is Harmony Biosciences Holdings Inc. stock safe for conservative investorsInsider Buying & Momentum Based Trading Signals - Fundação Cultural do Pará
Forecasting Harmony Biosciences Holdings Inc. price range with options dataWeekly Trade Summary & Stepwise Entry and Exit Trade Signals - newser.com
Deutsche Bank Raises Price Target on Harmony Biosciences to $47 From $36, Keeps Buy Rating - MarketScreener
Harmony Biosciences Holdings, I (HRMY) Stock Forecasts - Yahoo Finance
Using Python tools to backtest Harmony Biosciences Holdings Inc. strategiesWeekly Trend Recap & Verified Stock Trade Ideas - newser.com
Will Harmony Biosciences Holdings Inc. stock reach all time highs in 2025 - newser.com
Harmony Biosciences Holdings Inc (HRMY) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):